Tags

Type your tag names separated by a space and hit enter

The prospects for the SARS-CoV-2 pandemic in Africa.
EMBO Mol Med. 2020 06 08; 12(6):e12488.EM

Abstract

On December 31, 2019, the Chinese government officially announced the identification of a new type of coronavirus (SARS-CoV-2) as the etiological cause of a severe acute respiratory syndrome in Wuhan city, Hubei Province. Over the next weeks, SARS-CoV-2 caused a global pandemic as officially declared by the WHO on March 11, 2020, with confirmed cases and deaths in more than 166 countries. We are experiencing a worldwide phenomenon of unprecedented social and economic consequences. Since the beginning of the COVID-19 outbreak, there have been fears that the epidemic could strongly impact weaker healthcare systems in poor-resource settings, especially in Sub-Saharan Africa (SSA). The 2 million Chinese nationals that live and work in Africa could potentially contribute to the spread of COVID-19 on the continent.

Authors+Show Affiliations

Emerging Bacterial Pathogens Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan, Italy.Emerging Bacterial Pathogens Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

32301279

Citation

Quaresima, Virginia, et al. "The Prospects for the SARS-CoV-2 Pandemic in Africa." EMBO Molecular Medicine, vol. 12, no. 6, 2020, pp. e12488.
Quaresima V, Naldini MM, Cirillo DM. The prospects for the SARS-CoV-2 pandemic in Africa. EMBO Mol Med. 2020;12(6):e12488.
Quaresima, V., Naldini, M. M., & Cirillo, D. M. (2020). The prospects for the SARS-CoV-2 pandemic in Africa. EMBO Molecular Medicine, 12(6), e12488. https://doi.org/10.15252/emmm.202012488
Quaresima V, Naldini MM, Cirillo DM. The Prospects for the SARS-CoV-2 Pandemic in Africa. EMBO Mol Med. 2020 06 8;12(6):e12488. PubMed PMID: 32301279.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The prospects for the SARS-CoV-2 pandemic in Africa. AU - Quaresima,Virginia, AU - Naldini,Matteo M, AU - Cirillo,Daniela M, Y1 - 2020/05/05/ PY - 2020/4/18/pubmed PY - 2020/6/18/medline PY - 2020/4/18/entrez SP - e12488 EP - e12488 JF - EMBO molecular medicine JO - EMBO Mol Med VL - 12 IS - 6 N2 - On December 31, 2019, the Chinese government officially announced the identification of a new type of coronavirus (SARS-CoV-2) as the etiological cause of a severe acute respiratory syndrome in Wuhan city, Hubei Province. Over the next weeks, SARS-CoV-2 caused a global pandemic as officially declared by the WHO on March 11, 2020, with confirmed cases and deaths in more than 166 countries. We are experiencing a worldwide phenomenon of unprecedented social and economic consequences. Since the beginning of the COVID-19 outbreak, there have been fears that the epidemic could strongly impact weaker healthcare systems in poor-resource settings, especially in Sub-Saharan Africa (SSA). The 2 million Chinese nationals that live and work in Africa could potentially contribute to the spread of COVID-19 on the continent. SN - 1757-4684 UR - https://www.unboundmedicine.com/medline/citation/32301279/The_prospects_for_the_SARS_CoV_2_pandemic_in_Africa_ DB - PRIME DP - Unbound Medicine ER -